Ranking · Trials
Recruiting clinical trials
Interventional studies currently RECRUITING whose conditions map to this cancer or its descendants.
Computedci-recruiting-trials-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Recruiting clinical trials (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Lung Neoplasm | 1,428 | 100 | Medium confidence | clinicaltrials | inputs
ranking row 2580690 |
| 2 | = | Malignant Breast Neoplasm | 1,396 | 97.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580691 |
| 3 | = | Non-Hodgkin Lymphoma | 1,128 | 94.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580692 |
| 4 | = | Leukemia | 1,011 | 91.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580693 |
| 5 | = | Malignant Prostate Neoplasm | 744 | 88.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580694 |
| 6 | = | Malignant Liver Neoplasm | 530 | 85.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580695 |
| 7 | = | Malignant Pancreatic Neoplasm | 506 | 82.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580696 |
| 8 | = | Malignant Central Nervous System Neoplasm | 453 | 80 | Medium confidence | clinicaltrials | inputs
ranking row 2580697 |
| 9 | = | Multiple Myeloma | 414 | 77.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580698 |
| 10 | = | Malignant Ovarian Neoplasm | 385 | 74.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580699 |
| 11 | = | Malignant Gastric Neoplasm | 351 | 71.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580700 |
| 12 | = | Malignant Esophageal Neoplasm | 301 | 68.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580701 |
| 13 | = | Malignant Cervical Neoplasm | 279 | 65.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580702 |
| 14 | = | Malignant Kidney Neoplasm | 231 | 62.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580703 |
| 15 | = | Malignant Uterine Corpus Neoplasm | 226 | 60 | Medium confidence | clinicaltrials | inputs
ranking row 2580704 |
| 16 | = | Malignant Rectal Neoplasm | 215 | 57.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580705 |
| 17 | = | Malignant Bladder Neoplasm | 177 | 54.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580706 |
| 18 | = | Malignant Nasopharyngeal Neoplasm | 139 | 51.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580707 |
| 19 | = | Malignant Colon Neoplasm | 117 | 48.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580708 |
| 20 | = | Malignant Thyroid Gland Neoplasm | 92 | 45.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580709 |
| 21 | = | Hodgkin Lymphoma | 90 | 42.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580710 |
| 22 | = | Malignant Lip and Oral Cavity Neoplasm | 77 | 40 | Medium confidence | clinicaltrials | inputs
ranking row 2580711 |
| 22 | = | Malignant Oropharyngeal Neoplasm | 77 | 40 | Medium confidence | clinicaltrials | inputs
ranking row 2580712 |
| 24 | = | Skin Carcinoma | 69 | 34.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580713 |
| 25 | = | Malignant Mesothelioma | 55 | 31.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580714 |
| 26 | = | Malignant Laryngeal Neoplasm | 41 | 28.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580715 |
| 27 | = | Cutaneous Melanoma | 39 | 25.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580716 |
| 28 | = | Malignant Anal Neoplasm | 34 | 22.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580717 |
| 29 | = | Malignant Salivary Gland Neoplasm | 32 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580718 |
| 29 | = | Malignant Vulvar Neoplasm | 32 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580719 |
| 31 | = | Malignant Hypopharyngeal Neoplasm | 31 | 14.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580720 |
| 32 | = | Malignant Testicular Neoplasm | 26 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580721 |
| 33 | = | Malignant Penile Neoplasm | 22 | 8.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580722 |
| 34 | = | Malignant Vaginal Neoplasm | 20 | 5.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580723 |
| 35 | = | Malignant Gallbladder Neoplasm | 14 | 2.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580724 |
| 36 | = | Kaposi Sarcoma | 11 | 0 | Medium confidence | clinicaltrials | inputs
ranking row 2580725 |
Data updated 16 hours agoSource updated unknown36 eligible entities · inputs hash e254423b3e4889483596cf7d